Comparative Clinical Evaluation of the Efficacy of Topical Unani Formulations in the Management of Kalaf (Melasma)

Jamia Hamdard (Deemed to be university)0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年9月18日

试验速览

暂无简介。

•Patients of all genders, belonging to 18 to 60 years of age and willing to participate in the trial voluntarily.
•Clinically diagnosed patients of epidermal melasma using Wood’s lamp (340-400 nm).
•Patients willing to sign the informed consent form.

•Pregnant and lactating women.
•Female patient using oral contraceptives.
•Patients having field work jobs.
•Patients with drug or alcohol addiction.
•Patients with uncontrolled diabetes mellitus, renal disorders, severe liver, and heart diseases.
•Patients have used bleaching creams or topical steroid creams such as Azeliac acid, tretinoin and hydroquinone in the past 4 weeks before entering in the study.
•Patients who have undergone any laser therapies and chemical peeling or consuming photosensitizing substances in past 4 weeks.
•Patients having thyroid disorders.

发起方

Jamia Hamdard (Deemed to be university)